Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XAY.2.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.3.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.2.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DB.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CH.1.1.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CZ.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FK.1.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.80 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.43.8 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
AY.128 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.220EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.258.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.438EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.257EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.5.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.323EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.15EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.105 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.4 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.9 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
B.1.398EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.94 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.50EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.52EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
W.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.250EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.63EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.27EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.23EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.130EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.469EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.315EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.204EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used